Abramson Cancer Center At Penn Medicine
Clinical trials sponsored by Abramson Cancer Center At Penn Medicine, explained in plain language.
-
New injection plus chemo shows promise in early trial for stomach and esophagus cancers
Disease control Not yet recruitingThis study tests whether injecting a new treatment called RP2 directly into tumors, along with standard chemotherapy (FLOT), is safe and works better than chemotherapy alone before surgery. It involves 34 adults with stage 2 or higher stomach or esophagus cancer that hasn't sprea…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Can radiation and a common antibiotic boost CAR-T therapy for lymphoma?
Disease control Not yet recruitingThis early-stage trial tests whether giving radiation therapy and the antibiotic vancomycin before CAR-T cell treatment is safe and doable for people with large B-cell lymphoma. The study will enroll 14 adults whose lymphoma has come back or not responded to other treatments. The…
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Kidney cancer patients may get a break from treatment with targeted therapy
Disease control Not yet recruitingThis study tests whether giving focused radiation or surgery to all remaining cancer spots can allow kidney cancer patients to stop their regular treatment for at least a year. It involves 23 adults with metastatic clear cell kidney cancer who have already had stable or improved …
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New blood test could spot breast cancer earlier
Diagnosis Not yet recruitingThis study will check how well a new blood test, called SpotitEarly, can detect breast cancer in women. About 500 women will take part, including those at higher risk due to age, genetics, or family history. The goal is to see if the test is accurate and works well for different …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Apr 28, 2026 13:01 UTC
-
New app aims to help breast cancer patients stick with hormone therapy
Symptom relief Not yet recruitingThis study tests a mobile health tool to help women on hormone therapy for breast cancer understand and manage side effects. Researchers will enroll 60 women to see if the app is easy to use and helps them stay on their medication. The goal is to improve quality of life and treat…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC